FDA MedWatch News FDA Warnings
 
Ennis & Ennis, P.A. is a national law firm that specializes in mass torts, defective medical devices and product liablity cases. If you have been injured you need to know your legal rights. Contact the lawyers of Ennis & Ennis today for a free case evaluation.
Ennis & Ennis, P.A. News
Free Case Evaluation

FDA MedWatch


07/25/2008 -  FDA informed healthcare professionals that serious and sometimes fatal hypersensitivity reactions (HSR) caused by abacavir therapy are significantly more common in patients with a particular human leukocyte antigen (HLA) allele, HLA-B*5701. FDA reviewed data from two studies that support a recommendation for pre-therapy screening for the presence of the HLA-B*5701 allele and the selection of alternative therapy in positive subjects. Genetic tests for HLA-B*5701 are available and all patients should be screened for the HLA-B*5701 allele before starting or restarting treatment with abacavir or abacavir-containing medications. Development of clinically suspected abacavir HSR requires immediate and permanent discontinuation of abacavir therapy in all patients, including patients negative for HLA-B*5701.

Read the complete MedWatch 2008 Safety Summary, including a link to the  Information for Healthcare Professionals document, at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Abacavir

Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405